RYBIRTRA

Pharmaceutical preparations for the treatment of hematological, autoimmune, dermatological, immunological and inflammatory related diseases and disorders; pharmaceutical preparations for the treatment of complement-mediated neurological diseases and disorders; none of the foregoing being pharmaceutical preparations for the treatment of sialorrhea